TY - JOUR
T1 - Update on the prevalence and determinants of folic acid use in Japan evaluated with 91,538 pregnant women
T2 - the Japan Environment and Children’s Study
AU - on behalf of the JECS group
AU - Ishikawa, Tomofumi
AU - Obara, Taku
AU - Nishigori, Hidekazu
AU - Nishigori, Toshie
AU - Metoki, Hirohito
AU - Ishikuro, Mami
AU - Tatsuta, Nozomi
AU - Mizuno, Satoshi
AU - Sakurai, Kasumi
AU - Nishijima, Ichiko
AU - Murai, Yuriko
AU - Fujiwara, Ikuma
AU - Arima, Takahiro
AU - Nakai, Kunihiko
AU - Yaegashi, Nobuo
AU - Kuriyama, Shinichi
AU - Mano, Nariyasu
N1 - Funding Information:
The JECS was funded by the Ministry of the Environment, the Government of Japan.
Publisher Copyright:
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Objective: To provide the latest and most promising evidence on the prevalence and determinants for folic acid supplementation in pregnant women in Japan, including differences in prevalence between interview years and determinants across regions. Materials and methods: The study participants were enrolled from 15 regional centers across Japan between January 2011 and March 2014. Information on the use of folic acid supplementation before and during pregnancy and the characteristics of the participants were collected using questionnaires, medical chart reviews, and interviews by research coordinators. Results: Data for 91,538 women who provided sufficient data on folic acid supplementation were analyzed. The prevalence of adequate users was 8.0%, which, although low, tended to improve over the 4-year recruitment period. Various kinds of sociodemographic factors, lifestyle habits, and obstetrical and medication use history were significant and independent determinants for folic acid use. Associations between adequate preconception folic acid use and its major determinants tended to be similar across regions. Conclusions: Although the prevalence of adequate folic acid use was low, it increased from 2011 to 2014. Reproductive-aged women who have determinants for inadequate folic acid use should be informed about the need for preconception folic acid supplementation to help prevent neural tube defects.
AB - Objective: To provide the latest and most promising evidence on the prevalence and determinants for folic acid supplementation in pregnant women in Japan, including differences in prevalence between interview years and determinants across regions. Materials and methods: The study participants were enrolled from 15 regional centers across Japan between January 2011 and March 2014. Information on the use of folic acid supplementation before and during pregnancy and the characteristics of the participants were collected using questionnaires, medical chart reviews, and interviews by research coordinators. Results: Data for 91,538 women who provided sufficient data on folic acid supplementation were analyzed. The prevalence of adequate users was 8.0%, which, although low, tended to improve over the 4-year recruitment period. Various kinds of sociodemographic factors, lifestyle habits, and obstetrical and medication use history were significant and independent determinants for folic acid use. Associations between adequate preconception folic acid use and its major determinants tended to be similar across regions. Conclusions: Although the prevalence of adequate folic acid use was low, it increased from 2011 to 2014. Reproductive-aged women who have determinants for inadequate folic acid use should be informed about the need for preconception folic acid supplementation to help prevent neural tube defects.
KW - Folic acid
KW - Japan
KW - neural tube defects
KW - preconception
KW - pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85052138702&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052138702&partnerID=8YFLogxK
U2 - 10.1080/14767058.2018.1494712
DO - 10.1080/14767058.2018.1494712
M3 - Article
C2 - 29950122
AN - SCOPUS:85052138702
SN - 1476-7058
VL - 33
SP - 427
EP - 436
JO - Journal of Maternal-Fetal and Neonatal Medicine
JF - Journal of Maternal-Fetal and Neonatal Medicine
IS - 3
ER -